StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)

Close on Nov 16, 2026Market cap $6.07MP/E –Yield –

Biomerica ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Biomerica's ebitda for the twelve months ending Aug 31, 2026 was -$5.36M. For fiscal 2026 it was -$5.24M. The highest annual figure on record is $701.33K in fiscal 2013.

Annual ebitda

PeriodPeriod endValueChange
FY2026May 31, 2026-$5.24M–
FY2025May 31, 2025-$5.05M–
FY2024May 31, 2024-$6.29M–
FY2023May 31, 2023-$7.14M–
FY2022May 31, 2022-$4.20M–
FY2021May 31, 2021-$7.39M–
FY2020May 31, 2020-$2.64M–
FY2019May 31, 2019-$2.31M–
FY2018May 31, 2018-$1.37M–
FY2017May 31, 2017-$809.75K–
FY2016May 31, 2016-$670.67K–
FY2015May 31, 2015-$492.38K–
FY2014May 31, 2014-$269.08K-138.4%
FY2013May 31, 2013$701.33K+7.5%
FY2012May 31, 2012$652.30K–
FY2011May 31, 2011-$2.22K–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026-$1.21M–
Q4 FY2026CQ2 2026May 31, 2026-$1.52M–
Q3 FY2026CQ1 2026Feb 28, 2026-$1.28M–
Q2 FY2026CQ4 2025Nov 30, 2025-$1.35M–
Q1 FY2026CQ3 2025Aug 31, 2025-$1.10M–
Q4 FY2025CQ2 2025May 31, 2025-$1.54M–
Q3 FY2025CQ1 2025Feb 28, 2025-$1.19M–
Q2 FY2025CQ4 2024Nov 30, 2024-$971.00K–
Q1 FY2025CQ3 2024Aug 31, 2024-$1.35M–
Q4 FY2024CQ2 2024May 31, 2024-$1.51M–
Q3 FY2024CQ1 2024Feb 29, 2024-$1.98M–
Q2 FY2024CQ4 2023Nov 30, 2023-$1.59M–
Q1 FY2024CQ3 2023Aug 31, 2023-$1.21M–
Q4 FY2023CQ2 2023May 31, 2023-$1.82M–
Q3 FY2023CQ1 2023Feb 28, 2023-$1.64M–
Q2 FY2023CQ4 2022Nov 30, 2022-$1.65M–
Q1 FY2023CQ3 2022Aug 31, 2022-$2.04M–
Q4 FY2022CQ2 2022May 31, 2022-$1.50M–
Q3 FY2022CQ1 2022Feb 28, 2022-$81.50K–
Q2 FY2022CQ4 2021Nov 30, 2021-$1.10M–
Q1 FY2022CQ3 2021Aug 31, 2021-$1.51M–
Q4 FY2021CQ2 2021May 31, 2021-$1.70M–
Q3 FY2021CQ1 2021Feb 28, 2021-$2.14M–
Q2 FY2021CQ4 2020Nov 30, 2020-$1.69M–
Q1 FY2021CQ3 2020Aug 31, 2020-$1.87M–
Q4 FY2020CQ2 2020May 31, 2020-$798.32K–
Q3 FY2020CQ1 2020Feb 29, 2020-$891.06K–
Q2 FY2020CQ4 2019Nov 30, 2019-$465.42K–
Q1 FY2020CQ3 2019Aug 31, 2019-$480.06K–
Q4 FY2019CQ2 2019May 31, 2019-$741.72K–
Q3 FY2019CQ1 2019Feb 28, 2019-$684.81K–
Q2 FY2019CQ4 2018Nov 30, 2018-$457.55K–
Q1 FY2019CQ3 2018Aug 31, 2018-$427.49K–
Q4 FY2018CQ2 2018May 31, 2018-$620.57K–
Q3 FY2018CQ1 2018Feb 28, 2018-$294.50K–
Q2 FY2018CQ4 2017Nov 30, 2017-$260.83K–
Q1 FY2018CQ3 2017Aug 31, 2017-$194.81K–
Q4 FY2017CQ2 2017May 31, 2017-$314.72K–
Q3 FY2017CQ1 2017Feb 28, 2017-$284.03K–
Q2 FY2017CQ4 2016Nov 30, 2016-$182.04K–

More Biomerica figures

See a number that looks wrong?